Komal P.

Komal P. is a Senior Scientist in Immuno-Oncology Discovery at Merck, having previously served as a Scientist and held various research positions at notable institutions including Pandion Therapeutics and Weill Cornell Medicine. They obtained a Master's degree in Pharmaceutical Sciences from the University of Pittsburgh, where they focused on nuclear receptors and toxicological studies involving Erythropoietic Protoporphyria. Prior to that, Komal worked as a Research Assistant at Harvard Medical School and was involved in significant immunological research during their time as a Graduate Research Student.